0001209191-20-015654.txt : 20200303
0001209191-20-015654.hdr.sgml : 20200303
20200303185426
ACCESSION NUMBER: 0001209191-20-015654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200303
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heron Patrick J
CENTRAL INDEX KEY: 0001365617
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39231
FILM NUMBER: 20684826
MAIL ADDRESS:
STREET 1: 550 HAMILTON AVE., SUITE 100
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Passage BIO, Inc.
CENTRAL INDEX KEY: 0001787297
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822729751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO COMMERCE SQUARE
STREET 2: 2001 MARKET STREET, 28TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 2678660312
MAIL ADDRESS:
STREET 1: TWO COMMERCE SQUARE
STREET 2: 2001 MARKET STREET, 28TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-03
0
0001787297
Passage BIO, Inc.
PASG
0001365617
Heron Patrick J
601 UNION STREET
SEATTLE
WA
98101
1
0
1
0
Common Stock
2020-03-03
4
C
0
2977242
A
2977242
I
By Frazier Life Sciences IX, L.P.
Common Stock
2020-03-03
4
C
0
1049175
A
4026417
I
By Frazier Life Sciences IX, L.P.
Common Stock
2020-03-03
4
C
0
432802
A
4459219
I
By Frazier Life Sciences IX, L.P.
Common Stock
2020-03-03
4
P
0
550000
18.00
A
5009219
I
By Frazier Life Sciences IX, L.P.
Series A-1 Preferred Stock
2020-03-03
4
C
0
2977242
0.00
D
Common Stock
2977242
0
I
By Frazier Life Sciences IX, L.P.
Series A-2 Preferred Stock
2020-03-03
4
C
0
1049175
0.00
D
Common Stock
1049175
0
I
By Frazier Life Sciences IX, L.P.
Series B Preferred Stock
2020-03-03
4
C
0
432802
0.00
D
Common Stock
432802
0
I
By Frazier Life Sciences IX, L.P.
Each share of the issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on March 3, 2020.
These securities are held of record by Frazier Life Sciences IX, L.P. ("Frazier Life Sciences"), of which FHMLS IX, L.P. ("FHMLS L.P.") is the general partner. FHMLS IX, L.L.C. ("FHMLS LLC") is the general partner of FHMLS L.P. The reporting person and James N. Topper are the managing members of FHMLS LLC and may be deemed to have shared voting and dispositive power over the shares held by Frazier Life Sciences. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
/s/ Richard Morris as attorney-in-fact for Patrick J. Heron
2020-03-03